Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer

A series of novel amidino 2-substituted benzimidazoles linked to 1,4-disubstituted 1,2,3-triazoles were synthesized by implementation of microwave and ultrasound irradiation in click reaction and subsequent condensation of thus obtained 4-(1,2,3-triazol-1-yl)benzaldehyde with o-phenylenediamines. In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2018-01, Vol.143, p.1616-1634
Hauptverfasser: Bistrović, Andrea, Krstulović, Luka, Harej, Anja, Grbčić, Petra, Sedić, Mirela, Koštrun, Sanja, Pavelić, Sandra Kraljević, Bajić, Miroslav, Raić-Malić, Silvana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1634
container_issue
container_start_page 1616
container_title European journal of medicinal chemistry
container_volume 143
creator Bistrović, Andrea
Krstulović, Luka
Harej, Anja
Grbčić, Petra
Sedić, Mirela
Koštrun, Sanja
Pavelić, Sandra Kraljević
Bajić, Miroslav
Raić-Malić, Silvana
description A series of novel amidino 2-substituted benzimidazoles linked to 1,4-disubstituted 1,2,3-triazoles were synthesized by implementation of microwave and ultrasound irradiation in click reaction and subsequent condensation of thus obtained 4-(1,2,3-triazol-1-yl)benzaldehyde with o-phenylenediamines. In vitro antiproliferative screening of compounds performed on human cancer cell lines revealed that p-chlorophenyl-substituted 1,2,3-triazolyl N-isopropylamidine 10c and benzyl-substituted 1,2,3-triazolyl imidazoline 11f benzimidazoles had selective and potent cytostatic activities in the low nM range against non-small cell lung cancer cell line A549, which could be attributed to induction of apoptosis and primary necrosis. Additional Western blot analyses showed different mechanisms of cytostatic activity between compounds 10c and 11f that could be associated with the nature of aromatic substituent at 1-(1,2,3-triazolyl) and amidino moiety at C-5 position of benzimidazole ring. Specifically, compound 11f abrogated the activity of several protein kinases including TGM2, CDK9, SK1 and p38 MAPK, whereas compound 10c did not have profound effect on the activities of CDK9 and TGM2, but instead showed moderate downregulation of SK1 activity concomitant with a significant reduction in p38 MAPK. Further in silico structural analysis demonstrated that compound 11f bound slightly better to the ATP binding site of p38 MAPK compared to 10c, which correlated well with observed stronger decrement in the expression level of phospho-p38 MAPK elicited by 11f in comparison with 10c. [Display omitted] •Novel amidino 2-substituted benzimidazoles linked to 1,2,3-triazoles were prepared.•N-isopropylamidine 10c and imidazoline 11f benzimidazoles exhibited selective and potent effects against A549 cells in the low nM range.•Molecular docking analyses of 10c and 11f in the ATP binding site of p38 MAPK were carried out.•Inhibitory activity in A549 cells was associated with induction of apoptosis and primary necrosis.•Cytostatic and pro-apoptotic effects of 10c and 11f could be ascribed to multi-target inhibition.
doi_str_mv 10.1016/j.ejmech.2017.10.061
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1964269818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523417308632</els_id><sourcerecordid>1964269818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-7d6fc8023b2a38452acc3e80abbc42fd0afcb4400e1be57bb0c3f52dba5fd7e03</originalsourceid><addsrcrecordid>eNp9kcuOEzEQRS0EYsLAHyDkJQs6lO1-ZYOEhqc0EhtYW35UJ47cdrDdkWb-hX_FTQaWbOxS6d66ZR9CXjLYMmD92-MWjzOaw5YDG2prCz17RDZs6MdG8K59TDbAuWg6Ltor8iznIwB0PcBTcsV3TAho-w359QGz24c3NN-Fcqh1pipYql30ce-M8hTPyi-quBhonGiIZ_RUY7h3s7PqPnqkqlYuYHVmeooFQ6Hz4otrikp7LNSFg9OuxJTpFBOtMbQkVGVelX9mhibPyntqsB5-CXtqVDCYnpMnk_IZXzzc1-THp4_fb740t98-f715f9sY0fPSDLafzAhcaK7E2HZcGSNwBKW1aflkQU1Gty0AMo3doDUYMXXcatVNdkAQ1-T1Ze4pxZ8L5iJnl9dlVMC4ZMl2fcv73cjGKm0vUpNizgkneUpuVulOMpArGHmUFzByBbN2K5hqe_WQsOgZ7T_TXxJV8O4iwPrOs8Mks3FYP8G6hKZIG93_E34DDE6ltw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1964269818</pqid></control><display><type>article</type><title>Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Bistrović, Andrea ; Krstulović, Luka ; Harej, Anja ; Grbčić, Petra ; Sedić, Mirela ; Koštrun, Sanja ; Pavelić, Sandra Kraljević ; Bajić, Miroslav ; Raić-Malić, Silvana</creator><creatorcontrib>Bistrović, Andrea ; Krstulović, Luka ; Harej, Anja ; Grbčić, Petra ; Sedić, Mirela ; Koštrun, Sanja ; Pavelić, Sandra Kraljević ; Bajić, Miroslav ; Raić-Malić, Silvana</creatorcontrib><description>A series of novel amidino 2-substituted benzimidazoles linked to 1,4-disubstituted 1,2,3-triazoles were synthesized by implementation of microwave and ultrasound irradiation in click reaction and subsequent condensation of thus obtained 4-(1,2,3-triazol-1-yl)benzaldehyde with o-phenylenediamines. In vitro antiproliferative screening of compounds performed on human cancer cell lines revealed that p-chlorophenyl-substituted 1,2,3-triazolyl N-isopropylamidine 10c and benzyl-substituted 1,2,3-triazolyl imidazoline 11f benzimidazoles had selective and potent cytostatic activities in the low nM range against non-small cell lung cancer cell line A549, which could be attributed to induction of apoptosis and primary necrosis. Additional Western blot analyses showed different mechanisms of cytostatic activity between compounds 10c and 11f that could be associated with the nature of aromatic substituent at 1-(1,2,3-triazolyl) and amidino moiety at C-5 position of benzimidazole ring. Specifically, compound 11f abrogated the activity of several protein kinases including TGM2, CDK9, SK1 and p38 MAPK, whereas compound 10c did not have profound effect on the activities of CDK9 and TGM2, but instead showed moderate downregulation of SK1 activity concomitant with a significant reduction in p38 MAPK. Further in silico structural analysis demonstrated that compound 11f bound slightly better to the ATP binding site of p38 MAPK compared to 10c, which correlated well with observed stronger decrement in the expression level of phospho-p38 MAPK elicited by 11f in comparison with 10c. [Display omitted] •Novel amidino 2-substituted benzimidazoles linked to 1,2,3-triazoles were prepared.•N-isopropylamidine 10c and imidazoline 11f benzimidazoles exhibited selective and potent effects against A549 cells in the low nM range.•Molecular docking analyses of 10c and 11f in the ATP binding site of p38 MAPK were carried out.•Inhibitory activity in A549 cells was associated with induction of apoptosis and primary necrosis.•Cytostatic and pro-apoptotic effects of 10c and 11f could be ascribed to multi-target inhibition.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2017.10.061</identifier><identifier>PMID: 29133046</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>1,2,3-triazole ; Amidines - chemical synthesis ; Amidines - chemistry ; Amidines - pharmacology ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Benzimidazole ; Benzimidazoles - chemical synthesis ; Benzimidazoles - chemistry ; Benzimidazoles - pharmacology ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - pathology ; Cell Proliferation - drug effects ; Cells, Cultured ; Crystallography, X-Ray ; Dose-Response Relationship, Drug ; Drug Design ; Drug Screening Assays, Antitumor ; Humans ; Kinase ; Lung Neoplasms - drug therapy ; Lung Neoplasms - pathology ; Models, Molecular ; Molecular Structure ; Multitarget ; Non-small cell lung cancer (A549) ; p38 MAPK ; Protein Kinase Inhibitors - chemical synthesis ; Protein Kinase Inhibitors - chemistry ; Protein Kinase Inhibitors - pharmacology ; Protein Kinases ; Structure-Activity Relationship ; Triazoles - chemistry ; Triazoles - pharmacology</subject><ispartof>European journal of medicinal chemistry, 2018-01, Vol.143, p.1616-1634</ispartof><rights>2017 Elsevier Masson SAS</rights><rights>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-7d6fc8023b2a38452acc3e80abbc42fd0afcb4400e1be57bb0c3f52dba5fd7e03</citedby><cites>FETCH-LOGICAL-c362t-7d6fc8023b2a38452acc3e80abbc42fd0afcb4400e1be57bb0c3f52dba5fd7e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2017.10.061$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29133046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bistrović, Andrea</creatorcontrib><creatorcontrib>Krstulović, Luka</creatorcontrib><creatorcontrib>Harej, Anja</creatorcontrib><creatorcontrib>Grbčić, Petra</creatorcontrib><creatorcontrib>Sedić, Mirela</creatorcontrib><creatorcontrib>Koštrun, Sanja</creatorcontrib><creatorcontrib>Pavelić, Sandra Kraljević</creatorcontrib><creatorcontrib>Bajić, Miroslav</creatorcontrib><creatorcontrib>Raić-Malić, Silvana</creatorcontrib><title>Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A series of novel amidino 2-substituted benzimidazoles linked to 1,4-disubstituted 1,2,3-triazoles were synthesized by implementation of microwave and ultrasound irradiation in click reaction and subsequent condensation of thus obtained 4-(1,2,3-triazol-1-yl)benzaldehyde with o-phenylenediamines. In vitro antiproliferative screening of compounds performed on human cancer cell lines revealed that p-chlorophenyl-substituted 1,2,3-triazolyl N-isopropylamidine 10c and benzyl-substituted 1,2,3-triazolyl imidazoline 11f benzimidazoles had selective and potent cytostatic activities in the low nM range against non-small cell lung cancer cell line A549, which could be attributed to induction of apoptosis and primary necrosis. Additional Western blot analyses showed different mechanisms of cytostatic activity between compounds 10c and 11f that could be associated with the nature of aromatic substituent at 1-(1,2,3-triazolyl) and amidino moiety at C-5 position of benzimidazole ring. Specifically, compound 11f abrogated the activity of several protein kinases including TGM2, CDK9, SK1 and p38 MAPK, whereas compound 10c did not have profound effect on the activities of CDK9 and TGM2, but instead showed moderate downregulation of SK1 activity concomitant with a significant reduction in p38 MAPK. Further in silico structural analysis demonstrated that compound 11f bound slightly better to the ATP binding site of p38 MAPK compared to 10c, which correlated well with observed stronger decrement in the expression level of phospho-p38 MAPK elicited by 11f in comparison with 10c. [Display omitted] •Novel amidino 2-substituted benzimidazoles linked to 1,2,3-triazoles were prepared.•N-isopropylamidine 10c and imidazoline 11f benzimidazoles exhibited selective and potent effects against A549 cells in the low nM range.•Molecular docking analyses of 10c and 11f in the ATP binding site of p38 MAPK were carried out.•Inhibitory activity in A549 cells was associated with induction of apoptosis and primary necrosis.•Cytostatic and pro-apoptotic effects of 10c and 11f could be ascribed to multi-target inhibition.</description><subject>1,2,3-triazole</subject><subject>Amidines - chemical synthesis</subject><subject>Amidines - chemistry</subject><subject>Amidines - pharmacology</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Benzimidazole</subject><subject>Benzimidazoles - chemical synthesis</subject><subject>Benzimidazoles - chemistry</subject><subject>Benzimidazoles - pharmacology</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Cell Proliferation - drug effects</subject><subject>Cells, Cultured</subject><subject>Crystallography, X-Ray</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Design</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Kinase</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - pathology</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Multitarget</subject><subject>Non-small cell lung cancer (A549)</subject><subject>p38 MAPK</subject><subject>Protein Kinase Inhibitors - chemical synthesis</subject><subject>Protein Kinase Inhibitors - chemistry</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein Kinases</subject><subject>Structure-Activity Relationship</subject><subject>Triazoles - chemistry</subject><subject>Triazoles - pharmacology</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcuOEzEQRS0EYsLAHyDkJQs6lO1-ZYOEhqc0EhtYW35UJ47cdrDdkWb-hX_FTQaWbOxS6d66ZR9CXjLYMmD92-MWjzOaw5YDG2prCz17RDZs6MdG8K59TDbAuWg6Ltor8iznIwB0PcBTcsV3TAho-w359QGz24c3NN-Fcqh1pipYql30ce-M8hTPyi-quBhonGiIZ_RUY7h3s7PqPnqkqlYuYHVmeooFQ6Hz4otrikp7LNSFg9OuxJTpFBOtMbQkVGVelX9mhibPyntqsB5-CXtqVDCYnpMnk_IZXzzc1-THp4_fb740t98-f715f9sY0fPSDLafzAhcaK7E2HZcGSNwBKW1aflkQU1Gty0AMo3doDUYMXXcatVNdkAQ1-T1Ze4pxZ8L5iJnl9dlVMC4ZMl2fcv73cjGKm0vUpNizgkneUpuVulOMpArGHmUFzByBbN2K5hqe_WQsOgZ7T_TXxJV8O4iwPrOs8Mks3FYP8G6hKZIG93_E34DDE6ltw</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Bistrović, Andrea</creator><creator>Krstulović, Luka</creator><creator>Harej, Anja</creator><creator>Grbčić, Petra</creator><creator>Sedić, Mirela</creator><creator>Koštrun, Sanja</creator><creator>Pavelić, Sandra Kraljević</creator><creator>Bajić, Miroslav</creator><creator>Raić-Malić, Silvana</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180101</creationdate><title>Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer</title><author>Bistrović, Andrea ; Krstulović, Luka ; Harej, Anja ; Grbčić, Petra ; Sedić, Mirela ; Koštrun, Sanja ; Pavelić, Sandra Kraljević ; Bajić, Miroslav ; Raić-Malić, Silvana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-7d6fc8023b2a38452acc3e80abbc42fd0afcb4400e1be57bb0c3f52dba5fd7e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>1,2,3-triazole</topic><topic>Amidines - chemical synthesis</topic><topic>Amidines - chemistry</topic><topic>Amidines - pharmacology</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Benzimidazole</topic><topic>Benzimidazoles - chemical synthesis</topic><topic>Benzimidazoles - chemistry</topic><topic>Benzimidazoles - pharmacology</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Cell Proliferation - drug effects</topic><topic>Cells, Cultured</topic><topic>Crystallography, X-Ray</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Design</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Kinase</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - pathology</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Multitarget</topic><topic>Non-small cell lung cancer (A549)</topic><topic>p38 MAPK</topic><topic>Protein Kinase Inhibitors - chemical synthesis</topic><topic>Protein Kinase Inhibitors - chemistry</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein Kinases</topic><topic>Structure-Activity Relationship</topic><topic>Triazoles - chemistry</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bistrović, Andrea</creatorcontrib><creatorcontrib>Krstulović, Luka</creatorcontrib><creatorcontrib>Harej, Anja</creatorcontrib><creatorcontrib>Grbčić, Petra</creatorcontrib><creatorcontrib>Sedić, Mirela</creatorcontrib><creatorcontrib>Koštrun, Sanja</creatorcontrib><creatorcontrib>Pavelić, Sandra Kraljević</creatorcontrib><creatorcontrib>Bajić, Miroslav</creatorcontrib><creatorcontrib>Raić-Malić, Silvana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bistrović, Andrea</au><au>Krstulović, Luka</au><au>Harej, Anja</au><au>Grbčić, Petra</au><au>Sedić, Mirela</au><au>Koštrun, Sanja</au><au>Pavelić, Sandra Kraljević</au><au>Bajić, Miroslav</au><au>Raić-Malić, Silvana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>143</volume><spage>1616</spage><epage>1634</epage><pages>1616-1634</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>A series of novel amidino 2-substituted benzimidazoles linked to 1,4-disubstituted 1,2,3-triazoles were synthesized by implementation of microwave and ultrasound irradiation in click reaction and subsequent condensation of thus obtained 4-(1,2,3-triazol-1-yl)benzaldehyde with o-phenylenediamines. In vitro antiproliferative screening of compounds performed on human cancer cell lines revealed that p-chlorophenyl-substituted 1,2,3-triazolyl N-isopropylamidine 10c and benzyl-substituted 1,2,3-triazolyl imidazoline 11f benzimidazoles had selective and potent cytostatic activities in the low nM range against non-small cell lung cancer cell line A549, which could be attributed to induction of apoptosis and primary necrosis. Additional Western blot analyses showed different mechanisms of cytostatic activity between compounds 10c and 11f that could be associated with the nature of aromatic substituent at 1-(1,2,3-triazolyl) and amidino moiety at C-5 position of benzimidazole ring. Specifically, compound 11f abrogated the activity of several protein kinases including TGM2, CDK9, SK1 and p38 MAPK, whereas compound 10c did not have profound effect on the activities of CDK9 and TGM2, but instead showed moderate downregulation of SK1 activity concomitant with a significant reduction in p38 MAPK. Further in silico structural analysis demonstrated that compound 11f bound slightly better to the ATP binding site of p38 MAPK compared to 10c, which correlated well with observed stronger decrement in the expression level of phospho-p38 MAPK elicited by 11f in comparison with 10c. [Display omitted] •Novel amidino 2-substituted benzimidazoles linked to 1,2,3-triazoles were prepared.•N-isopropylamidine 10c and imidazoline 11f benzimidazoles exhibited selective and potent effects against A549 cells in the low nM range.•Molecular docking analyses of 10c and 11f in the ATP binding site of p38 MAPK were carried out.•Inhibitory activity in A549 cells was associated with induction of apoptosis and primary necrosis.•Cytostatic and pro-apoptotic effects of 10c and 11f could be ascribed to multi-target inhibition.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29133046</pmid><doi>10.1016/j.ejmech.2017.10.061</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2018-01, Vol.143, p.1616-1634
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_1964269818
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects 1,2,3-triazole
Amidines - chemical synthesis
Amidines - chemistry
Amidines - pharmacology
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Benzimidazole
Benzimidazoles - chemical synthesis
Benzimidazoles - chemistry
Benzimidazoles - pharmacology
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - pathology
Cell Proliferation - drug effects
Cells, Cultured
Crystallography, X-Ray
Dose-Response Relationship, Drug
Drug Design
Drug Screening Assays, Antitumor
Humans
Kinase
Lung Neoplasms - drug therapy
Lung Neoplasms - pathology
Models, Molecular
Molecular Structure
Multitarget
Non-small cell lung cancer (A549)
p38 MAPK
Protein Kinase Inhibitors - chemical synthesis
Protein Kinase Inhibitors - chemistry
Protein Kinase Inhibitors - pharmacology
Protein Kinases
Structure-Activity Relationship
Triazoles - chemistry
Triazoles - pharmacology
title Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A21%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20synthesis%20and%20biological%20evaluation%20of%20novel%20benzimidazole%20amidines%20as%20potent%20multi-target%20inhibitors%20for%20the%20treatment%20of%20non-small%20cell%20lung%20cancer&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Bistrovi%C4%87,%20Andrea&rft.date=2018-01-01&rft.volume=143&rft.spage=1616&rft.epage=1634&rft.pages=1616-1634&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2017.10.061&rft_dat=%3Cproquest_cross%3E1964269818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1964269818&rft_id=info:pmid/29133046&rft_els_id=S0223523417308632&rfr_iscdi=true